Minerva Surgical Prices $75M IPO

Minerva Surgical, a women’s health company focused on the treatment of abnormal uterine bleeding, priced its IPO of 6.25 million shares at $12 per share.

The gross proceeds of the offering are expected to be $75 million. Shares begin trading today on the Nasdaq under UTRS.

The offering is expected to close Oct. 26. The underwriters have a 30-day option to purchase up to an additional 937,500 shares.

J.P. Morgan, Piper Sandler, UBS and SVB Leerink are joint book-running managers for the offering.

Total
0
Shares
Related Posts
Read More

Authenticx Raises $20M in B Round

Blue Heron Capital led the round and was joined by Beringea, Indiana Next Level Fund/50 South Capital Advisors, High Alpha, Mutual Capital Partners, Signal Peak Ventures, Allos Ventures, Elevate Ventures, and M25.